ResearcherUniversity of CopenhagenActive in the last 2 years
Lara Magni
Matched on ORCID iD 0000-0003-3258-5800; OpenAlex author ID A5080162333. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper
Papers 5
- Human P2X7 receptor variants Gly150Arg and Arg276His polymorphisms have differential effects on risk association and cellular functions in pancreatic cancer. Co-author DOI 10.1186/s12935-024-03339-9↗
- The P2X7 Receptor Stimulates IL-6 Release from Pancreatic Stellate Cells and Tocilizumab Prevents Activation of STAT3 in Pancreatic Cancer Cells. Co-author DOI 10.3390/cells10081928↗
- Proton Pump Inhibitors Reduce Pancreatic Adenocarcinoma Progression by Selectively Targeting H+, K+-ATPases in Pancreatic Cancer and Stellate Cells. Co-author DOI 10.3390/cancers12030640↗
- Purinergic Signaling in Pancreas-From Physiology to Therapeutic Strategies in Pancreatic Cancer. Co-author DOI 10.3390/ijms21228781↗
- The Activity of Kv 11.1 Potassium Channel Modulates F-Actin Organization During Cell Migration of Pancreatic Ductal Adenocarcinoma Cells. Co-author DOI 10.3390/cancers11020135↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ivana Novak · 4 shared papers, 2020–2024 · strength 0.63
- Paper Human P2X7 receptor variants Gly150Arg and Arg276His polymorphisms have differential effects on risk association and ce… DOI 10.1186/s12935-024-03339-9↗
- Paper Purinergic Signaling in Pancreas-From Physiology to Therapeutic Strategies in Pancreatic Cancer. DOI 10.3390/ijms21228781↗
- Paper The P2X7 Receptor Stimulates IL-6 Release from Pancreatic Stellate Cells and Tocilizumab Prevents Activation of STAT3 i… DOI 10.3390/cells10081928↗
- Ganga Deshar · 2 shared papers, 2020–2024 · strength 0.36
- Marco Tozzi · 2 shared papers, 2020–2021 · strength 0.27
- Paper The P2X7 Receptor Stimulates IL-6 Release from Pancreatic Stellate Cells and Tocilizumab Prevents Activation of STAT3 i… DOI 10.3390/cells10081928↗
- Paper Proton Pump Inhibitors Reduce Pancreatic Adenocarcinoma Progression by Selectively Targeting H+, K+-ATPases in Pancreat… DOI 10.3390/cancers12030640↗
- Astrid Zedlitz Johansen · 1 shared paper, 2024 · strength 0.20
- Julia Sidenius Johansen · 1 shared paper, 2024 · strength 0.20
- Claudia Duranti · 2 shared papers, 2019–2020 · strength 0.20
- Paper Proton Pump Inhibitors Reduce Pancreatic Adenocarcinoma Progression by Selectively Targeting H+, K+-ATPases in Pancreat… DOI 10.3390/cancers12030640↗
- Paper The Activity of Kv 11.1 Potassium Channel Modulates F-Actin Organization During Cell Migration of Pancreatic Ductal Ade… DOI 10.3390/cancers11020135↗
- Annarosa Arcangeli · 2 shared papers, 2019–2020 · strength 0.20
- Paper Proton Pump Inhibitors Reduce Pancreatic Adenocarcinoma Progression by Selectively Targeting H+, K+-ATPases in Pancreat… DOI 10.3390/cancers12030640↗
- Paper The Activity of Kv 11.1 Potassium Channel Modulates F-Actin Organization During Cell Migration of Pancreatic Ductal Ade… DOI 10.3390/cancers11020135↗
- Sagar S. Manoli · 1 shared paper, 2019 · strength 0.09
- Thomas Schmidt · 1 shared paper, 2019 · strength 0.09
- Stefano Coppola · 1 shared paper, 2019 · strength 0.09
- Albrecht Schwab · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.